Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amantadine to Speed Awakening After Cardiac Arrest

NCT02486211 is registered in ClinicalTrials.gov with Jon Rittenberger, MD as lead sponsor.

NCT NCT02486211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02486211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amantadine to Speed Awakening After Cardiac Arrest
Lead sponsor
Jon Rittenberger, MD
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2015
Completion date
June 30, 2018
Enrollment
14 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anoxia, coma, heart arrest